Bank Of America Corp Concert Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.34 - $5.84 $19,056 - $25,643	4,391 Added 0.34%	1,308,386 $7.64 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $356,348 - $600,868	83,454 Added 6.84%	1,303,995 $8.74 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $598,029 - $1.36 Million	213,582 Added 21.21%	1,220,541 $5.14 Million
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $816 - $1,178	-299 Reduced 0.03%	1,006,959 $3.39 Million
Q4 2021 Feb 08, 2022	BUY	$2.69 - $4.22 $21,530 - $33,776	8,004 Added 0.8%	1,007,258 $3.17 Million
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $21,885 - $28,651	-6,904 Reduced 0.69%	999,254 $3.27 Million
Q2 2021 Sep 13, 2021	BUY	$3.77 - $5.24 $3.79 Million - $5.27 Million	1,006,158 New	1,006,158 $4.25 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.